NEW YORK (GenomeWeb News) – Research reagents company Rockland Immunochemicals today said it has purchased the Epi-Plus antibody product line from 21st Century Biochemicals for an undisclosed amount.

Epi-Plus antibodies are used for epigenetics research and have been validated by multi-assay methods, including dot blot testing using modified peptide arrays, Western blots, and chromatin immunoprecipitation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.